Q220 reflects the full impact of COVID-19, driving a downward slide in all segments For Q220, according ...
Mark Dickinson, Worldwide President of Cerenovus, discusses the Company’s focus on patients, innovation ...
Heavy-weight contender COVID-19 landed some brutal blows to revenue in Q220, but companies look for bett...
In Q220, all geographies experienced shrinkage in their AWC revenues with Single-use NPWT showing the sh...
Keith Boettiger, Vice President, Neuromodulation, Abbott discusses COVID-19 and the Company’s strategies...
We are pleased to announce that Tim Patrick has joined the team at SmartTRAK as Senior Manager of Corpor...
Headwinds increased in Q2 as COVID-19 shut down elective procedures and stay-at-home orders impacted tra...
The US Surgical Matrices Market collapsed in Q220, achieving sales of $227.3MM, off -39.4% YoY, as the e...
The US market for Hemostats and Sealants dropped precipitously by -32.4% YoY in Q220, as the effects of ...